Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleResearch and Reports

Diagnosis of Atypical HUS Using Genetic Testing

Sara Taylor, Ly Nguyen, Beija Piedra and Melissa Walters
American Society for Clinical Laboratory Science January 2019, 32 (1) 8-12; DOI: https://doi.org/10.29074/ascls.2018000646
Sara Taylor
Tarleton State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ly Nguyen
Tarleton State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beija Piedra
Tarleton State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Walters
Tarleton State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Peripheral blood displaying a significantly low platelet count (42,000/uL) and shistocyes. 100X magnification.

Tables

  • Figures
    • View popup
    Table 1.

    Diagnostic timeline

    TestPatient ResultReference Range
    Day 1Day 5Day 10Day 20Day 30Day 50
    WBC20.214.59.66.58.69.04.5–11 X 103/uL
    RBC2.48*2.182.442.532.642.864.0–5.4 X 106/uL
    HGB7.6*6.57.58.28.59.212.0–16.0 g/dL
    HCT24.0*19.623.226.227.929.636.0%–47.0%
    PLT46*52121143156186150–450 X 103/uL
    DIFF↑ PMN*↑ PMN↑ PMN1 meta, 1 myelo
    RBC morphology1+ poly1+ decryoOcc. Shisto*2+ aniso1+ polyOcc. Shisto2+ aniso1+ polyOcc. Shisto3+ aniso1+ macro1+ stomato1+ decryoOcc. Shisto3+ aniso1+ macroOcc. Shisto
    INR0.9§1.31.3 1.0
    APTT23.5§33.233.2 25.1–36.5 s
    FIB229†292635 200–400 mg/dL
    FDP>5, <20† <5 ug/mL
    SUN31*6920299207–18 mg/dL
    CR1.9*3.52.67.24.26.50.6–1.3 mg/dL
    ALT79*28191312 13–56 U/L
    AST257*59282223 15–37 U/L
    LDH746* 778439414 84–246 U/L
    CK-MB Low MI probability No evidence of acute MI
    Troponin I Low MI probability Developing or subclinical MI
    BNP 991 2744 <125 pg.mL
    C3 107.0‖ 84.4 90–180 mg/dL
    C4 25.7‖ 11.4 10–40 mg/dL
    Haptoglobin 8 40–240 mg/dL
    Shiga Toxin I Neg‡ Negative
    Shiga Toxin 2 Neg‡ Negative
    Cl. Diff.Neg Negative
    ADAMTS13 20# >60%
    Renal biopsy Changes consistent with toxemia of pregnancy with progression to frank TMA. Given history of recent pregnancy, this most likely represents HELLP syndrome. However, HUS, aHUS, and TTP cannot be excluded.
    • ↵* TMA suggested

    • ↵† DIC ruled out

    • ↵‡ HUS ruled out

    • ↵§ antiphospholipid antibody syndrome ruled out

    • ↵‖ aHUS falsely ruled out

    • ↵# TTP falsely suggested

    • Abbreviations: MI, myocardial infarction

    • View popup
    Table 2.

    aHUS susceptibility panel

    TestPatient Result, Day 10Reference Range
    aHUS susceptibility panelC3, CFB, CFH, CFHR1, CFHR3, CFHR5, CFI, MCP, THBD deletion analysisAllele 1: Deletion of CFHR3-CFHR1Allele 2: No deletion detectedNo deletions detected

    Deletion of CFHR3-CFHR1 on allele 1 suggestive of aHUS.

    PreviousNext
    Back to top

    In this issue

    American Society for Clinical Laboratory Science: 32 (1)
    American Society for Clinical Laboratory Science
    Vol. 32, Issue 1
    1 Jan 2019
    • Table of Contents
    • Index by author
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Diagnosis of Atypical HUS Using Genetic Testing
    (Your Name) has sent you a message from American Society for Clinical Laboratory Science
    (Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Diagnosis of Atypical HUS Using Genetic Testing
    Sara Taylor, Ly Nguyen, Beija Piedra, Melissa Walters
    American Society for Clinical Laboratory Science Jan 2019, 32 (1) 8-12; DOI: 10.29074/ascls.2018000646

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Request Permissions
    Share
    Diagnosis of Atypical HUS Using Genetic Testing
    Sara Taylor, Ly Nguyen, Beija Piedra, Melissa Walters
    American Society for Clinical Laboratory Science Jan 2019, 32 (1) 8-12; DOI: 10.29074/ascls.2018000646
    Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • ABSTRACT
      • CASE REPORT
      • LABORATORY FINDINGS
      • DISCUSSION
      • SUMMARY/CONCLUSION
      • References
    • Figures & Data
    • Info & Metrics
    • PDF

    Related Articles

    • No related articles found.
    • Google Scholar

    Cited By...

    • No citing articles found.
    • Google Scholar

    More in this TOC Section

    • Barriers to Implementation of Quality Management Systems in Laboratories: Lessons from the Southern Africa TB Health Systems Project
    • Polyagglutination: Lectin Isolation for T-Activated Red Cells
    • Strength of Direct Antiglobulin Test as an Indicator of Disease Severity in Autoimmune Hemolytic Anemia
    Show more Research and Reports

    Similar Articles

    Keywords

    • aHUS - atypical hemolytic uremic syndrome
    • ADAMTS13 - a disintegrin and metalloproteinase with a thrombospondin type 1 motif - member 13
    • ALT - alanine aminotransferase
    • AST - aspartate aminotransferase
    • APTT - activated partial thromboplastin
    • BNP - B-type natriuretic peptide
    • CBC - complete blood count
    • CFH - complement factor H
    • CK-MB - creatine kinase-muscle/brain
    • DIC - disseminated intravascular coagulation
    • FDP - fibrin degradation product
    • fH - factor H
    • HELLP - hemolysis - elevated liver enzymes - and low platelet count
    • HUS - hemolytic uremic syndrome
    • INR - international normalized ratio
    • LDH - lactate dehydrogenase
    • RBC - red blood cell
    • SUN - serum urea nitrogen
    • TMA - thrombotic microangiopathy
    • TTP - thrombotic thrombocytopenic purpura
    • WBC - white blood cell

    © 2025 The American Society for Clinical Laboratory Science

    Powered by HighWire